Promising gene therapy for FOXG1 syndrome
A viral gene therapy has reversed some brain abnormalities in infant mice with FOXG1 syndrome, a significant step toward one day treating children with this severe neurodevelopmental disorder.
Stay updated with breaking news from Molecular Therapy Methods. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A viral gene therapy has reversed some brain abnormalities in infant mice with FOXG1 syndrome, a significant step toward one day treating children with this severe neurodevelopmental disorder.
New publication shows groundbreaking result in FOXG1 AAV9 gene therapy studies, rescuing structural brain abnormalities caused by the pediatric rare disease,...
Many daily tasks, such as writing or buttoning a shirt, require fine motor skills. One aspect of fine motor skills is muscle strength. In order to write, for example, you Read More
Microbiology experts Tim Sandle, Tony Cundell and Miriam Guest reflect on key developments in pharmaceutical microbiology during 2022.
Researchers evaluate antiviral effects of CD63 tetraspanin extracellular vesicles against SARS-CoV-2 and HIV-1.